文献速递银屑病与炎症性皮肤病

居住地影响美国银屑病患者的医疗资源使用

Where you live matters: Regional differences in health care resource use for psoriasis in the United States.
PubMed 文献 · J Am Acad Dermatol · 2019-10-10

该横断面研究基于1996-2015年医疗支出面板调查,比较美国四个普查区域银屑病患者的医疗资源使用与费用。南部生物制剂使用比例最高但门诊和急诊就诊较少,中西部生物制剂可及性最低,西部总费用最低,东北部总费用最高。

要点

  • 南部生物制剂使用比例最高(9.1%),中西部最低(5.2%)。
  • 南部生物制剂使用比例高但门诊和急诊就诊比例较低。

核心结论

  • 美国南部生物制剂可及性最高且门诊和急诊就诊较少,中西部生物制剂及门诊急诊可及性最低。

研究设计与样本

  • 横断面研究,使用1996-2015年医疗支出面板调查(Medical Expenditure Panel Survey)数据。
  • 比较美国4个普查区域银屑病患者的医疗资源使用与费用。

主要发现

  • 生物制剂使用比例:南部9.1%、东北部7.4%、西部6.8%、中西部5.2%。
  • 人均年门诊次数:西部5.02、东北部3.81、南部2.95、中西部2.84。
  • 至少1次急诊就诊比例:东北部2.73%、西部2.17%、南部1.19%、中西部1.17%。

临床怎么用

  • 关注区域间生物制剂可及性差异,南部可及性较高但门诊随访可能不足。
  • 中西部生物制剂及门诊急诊资源可及性最低,需优化资源配置。
  • 西部总费用最低、东北部最高,费用控制可参考区域模式。

局限性

  • 数据中缺乏银屑病严重程度信息。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unknown which U.S. Census region offers the best access to health care resources. OBJECTIVE: To compare health care resource use and costs for patients with psoriasis among the 4 U.S. Census regions. METHODS: Cross-sectional study using the 1996-2015 Medical Expenditure Panel Survey. RESULTS: In the United States the greatest access for biologic medications was in the South (9.1% receiving biologic medications/year), followed by the Northeast (7.4%), the West (6.8%), and the Midwest (5.2%). Ambulatory visits per patient per year were highest in the West (5.02), followed by the Northeast (3.81), the South (2.95), and the Midwest (2.84). The proportion of patients with ≥1 emergency department (ED) visits was highest in the Northeast (2.73%), followed by the West (2.17%), the South (1.19%), and the Midwest (1.17%). Compared with the remainder of the country, the West incurred the lowest total health care costs (P = .035) and the lowest drug costs (P = .023); and the Northeast incurred the highest total health care costs (P = .050) and the highest ambulatory costs (P < .001). Although the South had the greatest proportion of patients using biologic medications (9.1% vs 6.4%, P = .045), it also had 30% fewer ambulatory visits per patient per year and a 39% lower proportion of ED visits for psoriasis. LIMITATIONS: Data for psoriasis severity were unavailable. CONCLUSIONS: Southern U.S. states have the greatest access to biologic medications and incurred fewer ambulatory and ED visits. The Midwest had the lowest access to biologic medications and ambulatory and ED care. The West incurred the lowest total health care costs, while the Northeast incurred the highest total health care costs.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Nguyen KB, Read C, Wu KK, et al. Where you live matters: Regional differences in health care resource use for psoriasis in the United States. J Am Acad Dermatol. 2019. PMID: 31606478. doi:10.1016/j.jaad.2019.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。